Medac   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Augusta GA United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
1992
NCT01060501
First Marketed Drug
2014
naltrexone (revia)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

medac GmbH | Medac GmbH (Hamburg, Germany) | Medac, Hamburg, Germany | MEDAC PHARMA INC | MedacSchering Onkologie